Last updated: June 4, 2021
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Sepsis And Septicemia
Low Blood Pressure (Hypotension)
Treatment
N/AClinical Study ID
NCT04915625
2021-0603
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age ≥ 18 years of age, gender-neutral;
- Diagnosed with sepsis shock;
- ICU survives longer than 48 h;
- The preservation of clinical data is complete;
Exclusion
Exclusion Criteria:
- Diagnosed with sepsis shock within 6 hours of emergency treatment; Combined with peoplewith autoimmune diseases; 3. Organ transplantation or immunosuppressive treatment; 4.Severe heart, liver and kidney insufficiency; 5. Late stage of malignant tumor; 6.Maternity; 7. Referral or referral to another hospital;
Study Design
Total Participants: 530
Study Start date:
December 01, 2020
Estimated Completion Date:
December 31, 2022
Connect with a study center
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Hanzhou, Zhejiang 310000
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.